Superficial bladder cancer.
Trybula
M
M
King
M
M
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002291:Carcinoma, Papillary / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D004317:Doxorubicin / Q000627:therapeutic use; D005009:Ethoglucid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D011379:Prognosis; D012176:Retinoids / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
D001500:BCG Vaccine; D008937:Mitomycins; D012176:Retinoids; D005009:Ethoglucid; D016685:Mitomycin; D004317:Doxorubicin; D007372:Interferons; D013852:Thiotepa